Health care companies recouped some of their recent losses amid generally strong earnings and deal activity. British drug maker AstraZeneca said it plans to invest $50 billion in the U.S. by 2030, ...

Replimune shares collapsed on Tuesday after the U.S. Food and Drug Administration rejected the clinical-stage biotechnology company's proposed advanced melanoma treatment. Shares of the Woburn, Mass., ...

FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency’s ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.: NNVC ) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...

No one doubts that rocket tests mean failures, but the question for Starship is this: Is it just having extended teething ...

The Starlab space station, scheduled to launch on Starship in 2028, passed five development and design milestones, moving the ...

Trans adult performer Angelina Please was found dead in her Las Vegas apartment on March 15, 2022 — nearly a week after she ...

Veterans with PTSD find healing through ibogaine treatments in Mexico while Texas passes legislation to become a leader in ...

Chemists have developed a novel way to generate a variety of highly useful chemical building blocks by harnessing metal ...

Ambitious study will profile thousands of tumor samples to uncover novel biomarkers and therapeutic targets for cancer and ...

Real change takes a long time, and when it happens, it must be recognized. The FDA and the NIH have announced their move away ...

Still, some challenges need to be worked out for companies eying the unique manufacturing process. For SpaceX, its plans ...